SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-08-040863
Filing Date
2008-06-30
Accepted
2008-06-30 16:16:28
Documents
2
Period of Report
2008-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd212038.html 3  
1 FORM 3 rrd212038.xml 3 2106
2 POWER OF ATTORNEY rrd189715_213930.htm EX-24. 3294
  Complete submission text file 0001181431-08-040863.txt   7289
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O OXIGENE, INC., 230 THIRD AVENUE WALTHAM MA 02451
Business Address 781-547-5900
Schwieterman William D (Reporting) CIK: 0001403961 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51462 | Film No.: 08926015